Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin 3 mg versus 5 mg starting dose in deep vein thrombosis
TCTR20180328002Phase 3Active, not recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of warfarin in deep vein thrombosis (DVT), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Aug 2009; status: active, not recruiting.
02
Drugs
warfarin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on TCTR20180328002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180328002.